Moses Jennifer K.

CIK 00017066672 companiesWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001706667

Recent Transactions

50 trades

Award
Viridian Therapeutics, Inc.\DE$VRDN
Stock Option (Right to Buy)
2025-07-01+21,000→ 21,000 total
Award
Viridian Therapeutics, Inc.\DE$VRDN
Stock Option (Right to Buy)
2024-06-26+21,000→ 21,000 total
Award
Viridian Therapeutics, Inc.\DE$VRDN
Stock Option (Right to Buy)
2023-06-14+20,000→ 20,000 total
Sale
G1 Therapeutics, Inc.
Common Stock
2023-01-05$5.41/sh−729→ 57,820 total
Sale
G1 Therapeutics, Inc.
Common Stock
2023-01-04$5.58/sh−1,639→ 58,549 total
Award
G1 Therapeutics, Inc.
Common Stock
2023-01-03+22,300→ 60,188 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to buy)
2023-01-03+44,600→ 44,600 total
Award
Viridian Therapeutics, Inc.\DE$VRDN
Stock Option (Right to Buy)
2022-06-08+12,500→ 12,500 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Option (Right to Buy)
2022-02-01−2,000→ 58,000 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2022-02-01−333→ 0 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2022-02-01$3.72/sh+333→ 35,888 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2022-02-01$4.17/sh+2,000→ 37,888 total
Sale
G1 Therapeutics, Inc.
Common Stock
2022-01-05$10.61/sh−1,445→ 35,555 total
Award
G1 Therapeutics, Inc.
Common Stock
2022-01-03+12,000→ 37,000 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to buy)
2022-01-03+53,000→ 53,000 total
Award
Viridian Therapeutics, Inc.\DE$VRDN
Stock Option (Right to Buy)
2021-07-14+25,000→ 25,000 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2021-03-03$3.72/sh+3,000→ 25,000 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2021-03-03−3,000→ 333 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2021-01-04+58,000→ 58,000 total
Award
G1 Therapeutics, Inc.
Common Stock
2021-01-04+11,000→ 22,000 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2020-03-13−2,000→ 3,333 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2020-03-13$3.72/sh+2,000→ 11,000 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2020-02-06+80,000→ 80,000 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2020-01-23$3.72/sh+1,000→ 9,000 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Option (Right to Buy)
2020-01-23−1,000→ 5,333 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2019-07-18$3.72/sh+2,000→ 8,000 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Option (Right to Buy)
2019-07-18−2,000→ 6,333 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to buy)
2019-05-08+50,000→ 50,000 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Option (Right to Buy)
2019-01-17−2,000→ 8,333 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2019-01-17$3.72/sh+2,000→ 6,000 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2019-01-02+20,000→ 20,000 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Option (Right to Buy)
2018-12-07−2,000→ 10,333 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2018-12-07$3.72/sh+2,000→ 4,000 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2018-12-06$0.39/sh+750→ 2,750 total
Sale
G1 Therapeutics, Inc.
Common Stock
2018-12-06$34.00/sh−750→ 2,000 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2018-12-06−750→ 1,666 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2018-11-05−750→ 2,416 total
Sale
G1 Therapeutics, Inc.
Common Stock
2018-11-05$41.38/sh−750→ 2,000 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2018-11-05$0.39/sh+750→ 2,750 total
Sale
G1 Therapeutics, Inc.
Common Stock
2018-10-08$44.52/sh−750→ 2,000 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2018-10-08−750→ 3,166 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2018-10-08$0.39/sh+750→ 2,750 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2018-09-05−750→ 3,916 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Options (Right to buy)
2018-09-05−2,000→ 12,333 total
Sale
G1 Therapeutics, Inc.
Common Stock
2018-09-05$59.60/sh−750→ 0 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2018-09-05$0.39/sh+750→ 750 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2018-09-05$3.72/sh+2,000→ 2,000 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2018-08-06$0.39/sh+750→ 750 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2018-08-06−750→ 4,666 total
Sale
G1 Therapeutics, Inc.
Common Stock
2018-08-06$50.79/sh−750→ 0 total

Companies

Recent Filings

Address

C/O VIRIDIAN THERAPEUTICS, INC. 221 CRESCENT STREET, SUITE 103A

WALTHAM, MA, 02453

View on SEC.gov